UroGen Pharma Ltd. (URGN) earnings
Quarterly results of UroGen Pharma Ltd. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
UroGen Pharma Ltd. is expected to report around March 1, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) UroGen Pharma Ltd. reported revenue of $89M (+223.9% on the same quarter a year earlier) and a net loss of $1.5M.
Diluted earnings per share were -$0.03.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $89M | +223.9% | -$1.5M | -$0.03 |
| Q2 FY2026 | $72.5M | +199.2% | -$14.4M | -$0.28 |
| Q1 FY2026 | $51M | +151.6% | -$23.6M | -$0.47 |
| Q4 FY2025 | $37.8M | +54% | -$26.4M | - |
| Q3 FY2025 | $27.5M | - | -$33.3M | -$0.69 |
| Q2 FY2025 | $24.2M | - | -$49.9M | -$1.05 |
| Q1 FY2025 | $20.3M | - | -$43.8M | -$0.92 |
| Q4 FY2024 | $24.6M | - | -$37.5M | -$0.80 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
When is UroGen Pharma Ltd.'s next earnings date?
UroGen Pharma Ltd. is expected to report around March 1, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were UroGen Pharma Ltd.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, UroGen Pharma Ltd. reported revenue of $89M and a net loss of $1.5M. The figures come from its filing with the SEC.
Is UroGen Pharma Ltd.'s revenue growing?
Revenue in Q3 FY2026 was $89M, up 223.9% from $27.5M in the same quarter a year earlier.
Get an email when URGN reports
Follow URGN and we email you its next results the day they are filed, with the numbers explained.